MDB Capital Holdings, LLC (MDBH) Q4 2025 Earnings Call Transcript
MDB Capital Holdings, LLC ( MDBH ) Q3 2025 Earnings Call November 20, 2025 4:30 PM EST Company Participants Tony Dammicci Christopher Marlett - Co-Founder, CEO & Chairman George Brandon - President, Head of Community Development & Director Presentation Tony Dammicci Welcome everyone to the MDB Capital Holdings' Third Quarter 2025 Update Conference Call. Thanks so much for joining us today.
MDB Capital Holdings, LLC (NASDAQ:MDBH ) Q4 2024 Earnings Conference Call March 31, 2025 4:30 PM ET Company Participants Kevin Cotter – Managing Director-Investment Banking Chris Marlett – Chief Executive Officer and Co-Founder Jeremy James – Chief Financial Officer Gary Schuman – Broker Dealer Chief Financial Officer and Head-Compliance Conference Call Participants Kevin Cotter [Call Starts Abruptly] will follow the formal presentation. If you have questions during the presentation, you can type them into the chat to be answered during the question-and-answer period.
| Capital Markets Industry | Financials Sector | Christopher A. Marlett CEO | NASDAQ (CM) Exchange | 55285N109 CUSIP |
| US Country | 16 Employees | - Last Dividend | - Last Split | - IPO Date |
MDB Capital Holdings, LLC is a diversified financial services firm that was established in 1997 and is headquartered in Addison, Texas. Through its subsidiaries, the company offers a broad range of services primarily focused on broker-dealer operations and technology development. It operates across two major segments: Broker Dealer & Intellectual Property Service, and Technology Development. The firm's dedication to innovation in both the financial and technological domains emphasizes its commitment to leveraging expertise for client success and technological advancement.
This segment represents the core financial services offered by MDB Capital Holdings, LLC. It functions as a full-service broker dealer, focusing on private and public securities offerings. In addition to facilitating securities transactions, this segment provides comprehensive research services aimed at investment banking due diligence. This dual focus on transaction facilitation and research-driven support embodies the firm's commitment to delivering value-added services to its clients, both issuers and investors.
The Technology Development segment underscores the company's engagement in the cutting-edge field of synthetic biology research and development. This initiative marks MDB Capital Holdings, LLC's diversification beyond traditional financial services into technology innovation. Through this segment, the company works on pioneering projects that have potential transformative impacts on industries and society. This segment reflects the company's forward-thinking approach and its ambition to drive progress in emerging technological fields.